A group termed “Frontline COVID-19 Critical Care Alliance” (FCCA) is still promoting ivermectin as a therapeutic agent for humans.  This group of physicians with unorthodox scientific values, who were opposed to conventional public health precautions during the COVID epidemic, claimed that ivermectin, a veterinary antiparasitic drug, could effectively treat this infection.  Their claim was based on in vitro experiments in which ivermectin apparently destroyed COVID virus in cell culture—an entirely expected outcome. 

Subsequent structured clinical trials failed to demonstrate any beneficial effect from administration of ivermectin. Unfortunately for political reasons the claim was embraced as a ‘quick fix” in Brazil and by some in the U.S. with unfortunate outcomes in terms of mortality.  The FCCA Group now claims that ivermectin is effective against a range of viral infections including respiratory syncytial virus, again without structured clinical trials. 

The World Health Organization and the Centers for Disease Control and Prevention have stated, unequivocally, that ivermectin had no therapeutic application in human medicine other than as an antiparasitic for immunosuppressed HIV patients.